SG11201805906WA - Diagnostic and prognostic methods for cardiovascular diseases and events - Google Patents
Diagnostic and prognostic methods for cardiovascular diseases and eventsInfo
- Publication number
- SG11201805906WA SG11201805906WA SG11201805906WA SG11201805906WA SG11201805906WA SG 11201805906W A SG11201805906W A SG 11201805906WA SG 11201805906W A SG11201805906W A SG 11201805906WA SG 11201805906W A SG11201805906W A SG 11201805906WA SG 11201805906W A SG11201805906W A SG 11201805906WA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- washington
- events
- pct
- applicant
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 5
- 208000024172 Cardiovascular disease Diseases 0.000 title abstract 3
- 235000018102 proteins Nutrition 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 238000003745 diagnosis Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000008520 organization Effects 0.000 abstract 1
- 229940070376 protein Drugs 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4884—Other medical applications inducing physiological or psychological stress, e.g. applications for stress testing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/50—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications
- A61B6/503—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications for diagnosis of the heart
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2871—Cerebrovascular disorders, e.g. stroke, cerebral infarct, cerebral haemorrhage, transient ischemic event
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Chemical & Material Sciences (AREA)
- Medical Informatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Physiology (AREA)
- Cardiology (AREA)
- Dentistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- High Energy & Nuclear Physics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Optics & Photonics (AREA)
- Radiology & Medical Imaging (AREA)
- Child & Adolescent Psychology (AREA)
- Developmental Disabilities (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662289513P | 2016-02-01 | 2016-02-01 | |
| US201662378535P | 2016-08-23 | 2016-08-23 | |
| PCT/US2017/016081 WO2017136464A1 (en) | 2016-02-01 | 2017-02-01 | Diagnostic and prognostic methods for cardiovascular diseases and events |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201805906WA true SG11201805906WA (en) | 2018-08-30 |
Family
ID=59500904
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201805906WA SG11201805906WA (en) | 2016-02-01 | 2017-02-01 | Diagnostic and prognostic methods for cardiovascular diseases and events |
Country Status (13)
| Country | Link |
|---|---|
| US (4) | US10983135B2 (https=) |
| EP (2) | EP3411720B1 (https=) |
| JP (4) | JP7134870B2 (https=) |
| KR (1) | KR20180101595A (https=) |
| CN (2) | CN108700596A (https=) |
| AU (1) | AU2017214469A1 (https=) |
| BR (1) | BR112018015698A2 (https=) |
| CA (1) | CA3012192A1 (https=) |
| MA (1) | MA43980A (https=) |
| MX (1) | MX2018009304A (https=) |
| RU (1) | RU2018130866A (https=) |
| SG (1) | SG11201805906WA (https=) |
| WO (1) | WO2017136464A1 (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3411720B1 (en) | 2016-02-01 | 2025-04-16 | Prevencio, Inc. | Diagnostic and prognostic methods for cardiovascular diseases and events |
| WO2019055609A1 (en) * | 2017-09-14 | 2019-03-21 | University Of Alabama At Birmingham | BIOMARKERS AND METHODS OF RISK ASSESSMENT OF MYOCARDIAL INFARCTION AND SEVERE INFECTION IN PATIENTS WITH RHEUMATOID ARTHRITIS |
| CA3081752A1 (en) * | 2017-11-02 | 2019-05-09 | Prevencio, Inc. | Diagnostic and prognostic methods for peripheral arterial diseases, aortic stenosis, and outcomes |
| US11009452B2 (en) | 2018-01-26 | 2021-05-18 | Viavi Solutions Inc. | Reduced false positive identification for spectroscopic quantification |
| US11656174B2 (en) | 2018-01-26 | 2023-05-23 | Viavi Solutions Inc. | Outlier detection for spectroscopic classification |
| ES3017793T3 (en) * | 2019-02-20 | 2025-05-13 | Fundacio Inst Dinvestigacio En Ciencies De La Salut Germans Trias I Pujol | In vitro method for predicting mortality risk in patients suffering from cardiogenic shock |
| CN110232975A (zh) * | 2019-05-20 | 2019-09-13 | 郑州大学第一附属医院 | 一种对糖尿病肾病患者3年内进入到肾脏替代治疗风险预测的方法 |
| CN110491512A (zh) * | 2019-08-08 | 2019-11-22 | 郑州大学第一附属医院 | 一种对肾活检确诊糖尿病肾病患者3年内进入到终末期肾脏病风险预测的方法 |
| CN110596399B (zh) * | 2019-08-29 | 2022-07-22 | 首都医科大学附属北京安贞医院 | 检测血管生成素样蛋白8含量的物质的应用 |
| CN110970131B (zh) * | 2019-10-24 | 2024-01-26 | 中国医科大学附属盛京医院 | 一种基于免疫球蛋白定量检测的肾小球疾病分类分型模型及其应用 |
| RU2726314C1 (ru) * | 2019-11-15 | 2020-07-14 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Тихоокеанский государственный медицинский университет" Министерства здравоохранения Российской Федерации | Способ раннего прогнозирования риска острого повреждения почек у пациентов с ишемической болезнью сердца после реваскуляризации миокарда методом аортокоронарного шунтирования |
| RU2760445C1 (ru) * | 2020-11-13 | 2021-11-25 | Виталий Юрьевич Мишланов | Способ диагностики патологических состояний человека |
| WO2022202360A1 (ja) * | 2021-03-23 | 2022-09-29 | テルモ株式会社 | 情報処理装置、情報処理方法およびプログラム |
| CN113342963B (zh) * | 2021-04-29 | 2022-03-04 | 山东大学 | 一种基于迁移学习的服务推荐方法及系统 |
| RU2770550C1 (ru) * | 2021-05-31 | 2022-04-18 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации | Способ прогнозирования сердечно-сосудистого риска с помощью определения уровня эстрогенов |
| EP4500552A2 (en) * | 2022-03-30 | 2025-02-05 | Inflammatix, Inc. | Methods for diagnosing myocardial infarction |
| CN114974576A (zh) * | 2022-07-12 | 2022-08-30 | 曜立科技(北京)有限公司 | 一种基于元数据的心脑血管数疾病诊断管理系统 |
| CN115185936B (zh) | 2022-07-12 | 2023-02-03 | 曜立科技(北京)有限公司 | 一种基于大数据的医疗临床数据质量分析系统 |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US20080202927A1 (en) | 2000-11-03 | 2008-08-28 | Clinical Micro Sensors, Inc. | Devices and methods for biochip multiplexing |
| US20030134433A1 (en) | 2002-01-16 | 2003-07-17 | Nanomix, Inc. | Electronic sensing of chemical and biological agents using functionalized nanostructures |
| US20060228723A1 (en) | 2002-01-16 | 2006-10-12 | Keith Bradley | System and method for electronic sensing of biomolecules |
| US9234867B2 (en) | 2003-05-16 | 2016-01-12 | Nanomix, Inc. | Electrochemical nanosensors for biomolecule detection |
| US8425745B2 (en) | 2006-10-06 | 2013-04-23 | Nanomix, Inc. | Electrochemical nanosensors for biomolecule detection |
| US8685711B2 (en) | 2004-09-28 | 2014-04-01 | Singulex, Inc. | Methods and compositions for highly sensitive detection of molecules |
| US20080269346A1 (en) * | 2005-02-17 | 2008-10-30 | University Of Florida Research Foundation, Inc. | B-Blocker Pharmacogenetics in Heart Failure |
| CN101495862A (zh) | 2005-06-24 | 2009-07-29 | 利兰·斯坦福青年大学托管委员会 | 诊断和监测动脉粥样硬化性心血管疾病的方法和组合物 |
| US8093017B2 (en) | 2005-12-07 | 2012-01-10 | Siemens Heathcare Diagnostics Inc. | Detection of soluble adiponectin receptor peptides and use in diagnostics and therapeutics |
| WO2007123708A2 (en) * | 2006-03-31 | 2007-11-01 | Epitome Biosystems, Inc. | Post translational modification pattern analysis |
| EP2302395B1 (en) | 2006-06-07 | 2015-04-15 | Health Diagnostic Laboratory, Inc. | Markers associated with arteriovascular events and methods of use thereof |
| PL2084543T3 (pl) * | 2006-10-26 | 2018-04-30 | B.R.A.H.M.S Gmbh | Stratyfikacja ryzyka ostrego zespołu wieńcowego za pomocą fragmentów/ częściowych peptydów prowazopresyny, a zwłaszcza kopeptyny lub neurofizyny II |
| WO2008131039A2 (en) * | 2007-04-16 | 2008-10-30 | Board Of Regents, The University Of Texas System | Cardibioindex/cardibioscore and utility of salivary proteome in cardiovascular diagnostics |
| US20100119600A1 (en) | 2007-06-01 | 2010-05-13 | Joar Opheim | Substances for reducing occurrence of major cardiac events comprising red yeast rice extract and omega-3 polyunsaturated fatty acid or derivative thereof |
| GB0717637D0 (en) | 2007-09-10 | 2007-10-17 | Univ Leiden | Future cardiac event biomarkers |
| US20100267062A1 (en) * | 2007-09-26 | 2010-10-21 | Norbert Frey | Osteopontin as Novel Prognostic Biomarker for Heart Failure |
| US8241861B1 (en) | 2008-07-08 | 2012-08-14 | Insilicos, Llc | Methods and compositions for diagnosis or prognosis of cardiovascular disease |
| JP5775868B2 (ja) | 2009-06-04 | 2015-09-09 | コーニンクレッカ フィリップス エヌ ヴェ | 不眠症のための行動療法を提供するシステム及びその制御方法 |
| JP5678045B2 (ja) * | 2009-06-08 | 2015-02-25 | シンギュレックス・インコーポレイテッド | 高感度バイオマーカーパネル |
| EP2467720A1 (en) | 2009-08-20 | 2012-06-27 | The Board of Regents of The University of Texas System | Methods and compositions for diagnosis of acute myocardial infarction (ami) |
| CN102762743A (zh) * | 2009-12-09 | 2012-10-31 | 阿维埃尔公司 | 用于心血管疾病的诊断和分类的生物标记物检验 |
| KR101256928B1 (ko) | 2010-01-20 | 2013-04-19 | 주식회사디엔에이링크 | 비만 또는 당뇨에 관련된 단일염기다형성 및 그의 용도 |
| WO2012058313A2 (en) * | 2010-10-27 | 2012-05-03 | The Broad Institute Of Mit And Harvard | Novel biomarkers for cardiovascular injury |
| WO2012072595A1 (en) * | 2010-11-30 | 2012-06-07 | Universiteit Gent | Platelet factor 4 variant for the prognosis of cardiovascular outcome in patients having heart disease |
| CN103502795B (zh) | 2011-03-09 | 2016-02-24 | 阿比奥尼克公司 | 选择性功能化的纳米流体生物传感器中的生物分子的快速定量及其方法 |
| WO2012145037A1 (en) * | 2011-04-19 | 2012-10-26 | Scott & White Healthcare | Novel apoc-i isoforms and their use as biomarkers and risk factors of atherosclerotic disease |
| US20140011811A1 (en) * | 2011-10-06 | 2014-01-09 | The United States Government As Represented By The Department Of Veterans Affairs | Myosin binding protein-c for use in methods relating to diastolic heart failure |
| EP2920722B1 (en) * | 2012-11-16 | 2021-01-20 | Siemens Healthcare Diagnostics Inc. | Method to identify optimum coronary artery disease treatment |
| WO2015006713A1 (en) | 2013-07-12 | 2015-01-15 | Emory University | Diagnostic assay to predict cardiovascular risk |
| PT3021968T (pt) | 2013-07-17 | 2018-12-19 | Abionic Sa | Método e dispositivo para ensaios biológicos |
| WO2015085314A2 (en) * | 2013-12-06 | 2015-06-11 | Diadexus, Inc. | Methods for detection of heart failure |
| US10509044B2 (en) * | 2014-05-08 | 2019-12-17 | University Of Maryland, Baltimore | Methods for assessing differential risk for developing heart failure |
| AU2015283689B2 (en) | 2014-07-03 | 2020-07-16 | Abionic Sa | Capsule for rapid molecular quantification of a fluid sample such as whole blood |
| EP3411720B1 (en) | 2016-02-01 | 2025-04-16 | Prevencio, Inc. | Diagnostic and prognostic methods for cardiovascular diseases and events |
| JP7310591B2 (ja) | 2019-12-19 | 2023-07-19 | 株式会社オートネットワーク技術研究所 | 駆動装置 |
-
2017
- 2017-02-01 EP EP17748086.0A patent/EP3411720B1/en active Active
- 2017-02-01 CN CN201780011650.8A patent/CN108700596A/zh active Pending
- 2017-02-01 EP EP25170203.1A patent/EP4574024A3/en active Pending
- 2017-02-01 RU RU2018130866A patent/RU2018130866A/ru not_active Application Discontinuation
- 2017-02-01 MX MX2018009304A patent/MX2018009304A/es unknown
- 2017-02-01 KR KR1020187024496A patent/KR20180101595A/ko not_active Withdrawn
- 2017-02-01 CA CA3012192A patent/CA3012192A1/en active Pending
- 2017-02-01 US US16/073,754 patent/US10983135B2/en active Active
- 2017-02-01 CN CN202210116587.7A patent/CN114441773A/zh active Pending
- 2017-02-01 SG SG11201805906WA patent/SG11201805906WA/en unknown
- 2017-02-01 MA MA043980A patent/MA43980A/fr unknown
- 2017-02-01 WO PCT/US2017/016081 patent/WO2017136464A1/en not_active Ceased
- 2017-02-01 JP JP2018559674A patent/JP7134870B2/ja active Active
- 2017-02-01 BR BR112018015698A patent/BR112018015698A2/pt not_active Application Discontinuation
- 2017-02-01 AU AU2017214469A patent/AU2017214469A1/en not_active Abandoned
-
2020
- 2020-10-27 US US17/081,776 patent/US11977083B2/en active Active
-
2021
- 2021-06-10 JP JP2021097387A patent/JP7403498B2/ja active Active
-
2022
- 2022-09-21 JP JP2022150335A patent/JP2022171936A/ja not_active Withdrawn
-
2023
- 2023-06-21 US US18/339,066 patent/US12146888B2/en active Active
-
2024
- 2024-10-11 US US18/913,852 patent/US20250060374A1/en active Pending
- 2024-12-09 JP JP2024214563A patent/JP2025029196A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20250060374A1 (en) | 2025-02-20 |
| EP3411720B1 (en) | 2025-04-16 |
| US20210072260A1 (en) | 2021-03-11 |
| US10983135B2 (en) | 2021-04-20 |
| CN108700596A (zh) | 2018-10-23 |
| US20230341418A1 (en) | 2023-10-26 |
| EP3411720C0 (en) | 2025-04-16 |
| CN114441773A (zh) | 2022-05-06 |
| WO2017136464A1 (en) | 2017-08-10 |
| MX2018009304A (es) | 2019-01-10 |
| AU2017214469A1 (en) | 2018-07-26 |
| JP2022171936A (ja) | 2022-11-11 |
| US11977083B2 (en) | 2024-05-07 |
| JP2019507354A (ja) | 2019-03-14 |
| EP3411720A1 (en) | 2018-12-12 |
| US12146888B2 (en) | 2024-11-19 |
| CA3012192A1 (en) | 2017-08-10 |
| EP4574024A2 (en) | 2025-06-25 |
| EP3411720A4 (en) | 2019-08-14 |
| RU2018130866A (ru) | 2020-03-04 |
| MA43980A (fr) | 2018-12-12 |
| JP7403498B2 (ja) | 2023-12-22 |
| BR112018015698A2 (pt) | 2018-12-26 |
| JP7134870B2 (ja) | 2022-09-12 |
| EP4574024A3 (en) | 2025-10-08 |
| KR20180101595A (ko) | 2018-09-12 |
| US20190369120A1 (en) | 2019-12-05 |
| JP2025029196A (ja) | 2025-03-05 |
| JP2021128177A (ja) | 2021-09-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201805906WA (en) | Diagnostic and prognostic methods for cardiovascular diseases and events | |
| SG11201904942YA (en) | Blockchain-based service execution method and apparatus, and electronic device | |
| SG11201901834WA (en) | Micrornas as biomarkers for endometriosis | |
| SG11201809913PA (en) | Methods for detecting target nucleic acids in a sample | |
| SG11201811740WA (en) | Systems and methods for identifying risky driving behavior | |
| SG11201909160WA (en) | Multispecific polypeptide constructs having constrained cd3 binding and methods of using the same | |
| SG11201805422WA (en) | Multivalent and multispecific ox40-binding fusion proteins | |
| SG11201910019PA (en) | Microorganisms and methods for producing cannabinoids and cannabinoid derivatives | |
| SG11201908767QA (en) | Method for accurate diagnosis of a disease targeting biomarkers in liquid biopsy | |
| SG11201906413XA (en) | Exposure apparatus | |
| SG11201908743SA (en) | Methods and compositions for modulation of immune cells | |
| SG11201908238SA (en) | Anti-c5 antibodies and uses thereof | |
| SG11201906778RA (en) | Improved methods for assessing risk of developing breast cancer | |
| SG11201809793UA (en) | Tl1a antibodies and uses thereof | |
| SG11201900293PA (en) | Method and device for displaying application information | |
| SG11201807719SA (en) | Use of clinical parameters for the prediction of sirs | |
| SG11201909807TA (en) | Methods of manufacturing of niraparib | |
| SG11201806432PA (en) | Methods for assessing risk of developing colorectal cancer | |
| SG11201809474TA (en) | Compositions and methods for bioengineered tissues | |
| SG11201811550XA (en) | Demand prediction for time-expiring inventory | |
| SG11201900589PA (en) | Methods for gynecologic neoplasm diagnosis | |
| SG11201906313SA (en) | A polypeptide linker for preparing multispecific antibodies | |
| SG11201903602RA (en) | Use of beta-catenin as a biomarker for treating cancers using anti-dkk-1 antibody | |
| SG11201811238YA (en) | Systems and methods for stations loading and display | |
| SG11201805440RA (en) | Diagnosis of unstable angina |